Cholesterol Testing Product & Services Market

Cholesterol Testing Product & Services Market by Types of Customer (Diagnostic Centers, Physicians/Providers & Hospitals, and Government Agencies) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-799
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 184
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global cholesterol testing product & services market size is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the increasing occurrence of elevated cholesterol levels in patients and prevalence of several disease such as diabetes, heart diseases, and obesity. The sedentary lifestyle of people and limited physical activities are the key factors for increasing cholesterol problems.
 

Cholesterol Testing Product & Services Market Key Takeaways


Cholesterol is one of the most common organic molecules found in every living organisms. It is biosynthesized from the animal cells present in the body and acts as a structural membrane for the animal cell crystalline solid. It serves as a foundation for the creation of a variety of hormones and vitamins such as steroid hormones and vitamin D.

On the basis of lipoproteins, cholesterol can be bifurcated into two category namely the low density lipoprotein (LDL) and the high density lipoprotein (HDL). Hospitals and healthcare clinics are conducting multiple tests to measure various levels of cholesterol in the patient’s blood. The most common cholesterol is referred to as a lipid profile. A lipid profile is conducted for the measurement of triglycerides and cholesterol in the patient’s blood. The LDL is contemplated to be the “bad” cholesterol as the main contribution of fatty buildups in the arteries that comes under the LDL. This results in the narrowing of arteries in the patient’s body and thereby risking a patient from stroke, peripheral artery disease, and heart attack. HDL, on the other hand, is considered the “good” cholesterol as a healthy level of HDL can strengthen the arteries next to the patient’s heart, thereby, protecting from fatalities. The main function of HDL is to carry away LDL from the arteries to the liver. The liver breaks the LDL into the required nutrients and passes the remaining from the body.

As per the guidelines by World Health Organization (WHO), people who are above the age of 18 years are advised to conduct testing for examining cholesterol levels and monitor several issues related to cholesterol problems in an interval of five years. Several researchers and scientists recently pointed out that the COVID-19 virus has the viral gene of accelerating illness of the hosts and a patient of high LDL cholesterol was more susceptible to the virus. This leads to high adoption of the testing procedures in hospitals, clinics, and healthcare laboratories for the prevention and treatment of diseases.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising awareness of regular checking of cholesterol levels and benefits of testing products to control the levels are the major drivers for the global cholesterol testing product & services market.
  • Increasing occurrence of several cholesterol-based health conditions such as obesity and other cardiovascular diseases is expected to boost the market expansion.
  • Favorable government regulations and their various healthcare initiatives to encourage regular testing process acts as a key driver for the global cholesterol testing product & services market.
  • The outbreak of COVID-19 pandemic has affected the global cholesterol testing product & services market initially. However, upon further studies, patients, having cholesterol problems, are expected to be susceptible to the COVID virus. This is further expected to propel the market.
  • High cost of lipid tests and lack of advanced medical facilities in many part of developing regions present key challenges that can hamper the market expansion in the coming years.

Scope of the Report

The report on the global cholesterol testing product & services market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Cholesterol Testing Product & Services Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types of Customer (Diagnostic Centers, Physicians/Providers & Hospitals, and Government Agencies)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

Quest Diagnostics Incorporated; Cell Biolabs Inc; Bio-Reference Laboratories Inc; Eurofins Scientific; Randox Laboratories Ltd; Synlab International GmbH; Thermo Fisher Scientific; and Clinical Reference Laboratory Inc.

 

Global Cholesterol Testing Product & Services Market Segment Insights

Diagnostic centers segment to dominate the market
On the basis of types of customer, the global cholesterol testing product & services market is divided into diagnostic centers, physicians/providers & hospitals, and government agencies. The diagnostic centers held a large market share in 2019 and is anticipated to dominate the market during the forecast period, 2021-2028. This growth is attributed to the increasing investment of medical funding towards the production of advanced diagnostic centers around the globe. However, the physicians/providers & hospitals segment is anticipated to exhibit a robust CAGR during the forecast period owing to increasing preference for hospitals and inclination towards visiting individual physicians to consult or conduct testing in hospitals.
 

Cholesterol Testing Product & Services Market By Types of Customer


North America represented a large revenue market share
In terms of regions, the market is classified as Asia Pacific, North Amaerica, Latin America, Europe, and Middle East & Africa. North America generated a large market share in 2018 and is expected to continue this trend during the forecast period, 2021-2028. The presence of major key players and existing advanced healthcare facilities in this region especially in the US. In the United Health Foundation’s annual report, the US was recorded to have the highest obesity rate in the world with 31.6%. Meanwhile, the market in Asia Pacific is anticipated to exhibit a high CAGR in the global cholesterol testing product & services market during the forecast period as the incidence of cholesterol problems is growing among the population of countries such as India and China.
 

Cholesterol Testing Product & Services Market by Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cholesterol Testing Product & Services Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cholesterol Testing Product & Services Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cholesterol Testing Product & Services Market - Supply Chain
  4.5. Global Cholesterol Testing Product & Services Market Forecast
     4.5.1. Cholesterol Testing Product & Services Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cholesterol Testing Product & Services Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Cholesterol Testing Product & Services Market Absolute $ Opportunity
5. Global Cholesterol Testing Product & Services Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Cholesterol Testing Product & Services Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
6. North America Cholesterol Testing Product & Services Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Cholesterol Testing Product & Services Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
7. Latin America Cholesterol Testing Product & Services Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Cholesterol Testing Product & Services Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
8. Europe Cholesterol Testing Product & Services Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Cholesterol Testing Product & Services Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
9. Asia Pacific Cholesterol Testing Product & Services Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Cholesterol Testing Product & Services Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
10. Middle East & Africa Cholesterol Testing Product & Services Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Cholesterol Testing Product & Services Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Cholesterol Testing Product & Services Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Cholesterol Testing Product & Services Market: Market Share Analysis
  11.2. Cholesterol Testing Product & Services Distributors and Customers
  11.3. Cholesterol Testing Product & Services Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Quest Diagnostics Incorporated
     11.4.2. Cell Biolabs Inc
     11.4.3. Bio-Reference Laboratories Inc
     11.4.4. Eurofins Scientific
     11.4.5. Randox Laboratories Ltd&l

Segments Covered in the Report
The global cholesterol testing product & services market has been segmented in terms of

Types of Customer

  • Diagnostic Centres
  • Physicians/Providers & Hospitals
  • Government Agencies

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Quest Diagnostics Incorporated
  • Cell Biolabs Inc
  • Bio-Reference Laboratories Inc
  • Eurofins Scientific
  • Randox Laboratories Ltd
  • Synlab International GmbH
  • Thermo Fisher Scientific
  • Clinical Reference Laboratory Inc

Some of the major players in the global cholesterol testing product & services market are Quest Diagnostics Incorporated; Cell Biolabs Inc; Bio-Reference Laboratories Inc; Eurofins Scientific; Randox Laboratories Ltd; Synlab International GmbH; Thermo Fisher Scientific; and Clinical Reference Laboratory Inc. Most of these players are currently engaged in strategic initiatives including mergers & acquisitions, promoting awareness, and new product development. Quest Diagnostics Incorporated, in 2017, launched the first non-fasting and novel cholesterol testing method, which showed a more precise and accurate LDL calculation.
 

Cholesterol Testing Product & Services Market By Key Players

Buy Report